Registration open for 13th Annual Meeting of the Society of Hematologic Oncology

The Society of Hematologic Oncology (SOHO) has opened registration for its annual meeting; register before June 8, 2025, for early-bird rates.

Event dates: September 3–6, 2025
Location: Houston, Texas

HOUSTON, Jan. 15, 2025 /PRNewswire/ — The Society of Hematologic Oncology (SOHO) has announced that registration is now open for its Thirteenth Annual Meeting, taking place September 3–6, 2025, in Houston, Texas. This premier event brings together global leaders in hematologic oncology to explore the latest advancements in the field, with a special focus this year on artificial intelligence (AI) and its transformative impact on research and treatment. 

The meeting will include keynote lectures, panel discussions, abstract presentations, and opportunities to network with thought leaders and colleagues from around the world. 

The theme of this year’s meeting, 2025: A Hematology Odyssey – Unleashing AI, Genomics, Targets, and Immune Engineering, was chosen by SOHO President Phillip Scheinberg, MD, PhD, chief of hematology at the Hospital A Beneficência Portuguesa de São Paulo in Brazil.

“These emerging frontiers are reshaping hematologic oncology, revolutionizing how we understand, diagnose, and treat hematologic malignancies, unlocking new possibilities for care and cures like never before,” Dr. Scheinberg said.

The meeting will feature three plenary talks by distinguished experts including: 

Wednesday, September 3
Sagar Lonial, MD, FACP
Emory University Winship Cancer Institute

Thursday, September 4
Jennifer R. Brown, MD, PhD
Dana-Farber Cancer Institute 

Friday, September 5
TBA*

Registrants are eligible for an early bird discount if registered before June 8. SOHO members enjoy a 40% discount on registration. Membership in SOHO is free, making it easy for professionals in the field to join and take advantage of this significant savings. For questions related to the SOHO Annual Meeting, please email admin@isoho.org.

SOHO 2025 offers a forum for industry sponsors to participate in the exchange of information and ideas surrounding cutting-edge developments in the field of hematologic malignancies. Sponsorship opportunities are available, and interested parties may visit soho.click/sponsors or may contact Belinda Melder at bmelder@jwccllc.org with any questions.  

News from SOHO 2025 will be posted in SOHO’s premier newspaper, SOHO Insider in print and online. Follow SOHO on social media for all the latest updates.

About SOHO*

The Society of Hematologic Oncology (SOHO) was established as a nonprofit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, nearly 10,000 members from 120 countries have joined the society. SOHO’s mission is to expedite worldwide research and education through the exchange of scientific information.

About SOHO Insider*

SOHO Insider is the premier news source of SOHO. Launched in December 2024, SOHO Insider aims to be a resource for hematologic oncologist worldwide. 

*Not affiliated with Blood Cancers Today or Mashup Media/AMC Media Group/Formedics.

View original content to download multimedia:https://www.prnewswire.com/news-releases/registration-open-for-13th-annual-meeting-of-the-society-of-hematologic-oncology-302352520.html

SOURCE Society of Hematologic Oncology

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

21 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

21 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

21 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

21 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

21 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

21 hours ago